Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands

Recent clinical developments in antitumor immunotherapy involving T-cell related therapeutics have led to a renewed interest for human leukocyte antigen class I (HLA-I) binding peptides, given their potential use as peptide vaccines. Databases of HLA-I binding peptides hold therefore information on...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Marta A. S., Bassani-Sternberg, Michal, Coukos, George, Gfeller, David, Zoete, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883762/
https://www.ncbi.nlm.nih.gov/pubmed/31824508
http://dx.doi.org/10.3389/fimmu.2019.02731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883762/
https://www.ncbi.nlm.nih.gov/pubmed/31824508
http://dx.doi.org/10.3389/fimmu.2019.02731

Ejemplares similares